- Previous Close
0.2550 - Open
0.2500 - Bid 0.2450 x --
- Ask 0.2500 x --
- Day's Range
0.2450 - 0.2500 - 52 Week Range
0.2450 - 0.7150 - Volume
318,216 - Avg. Volume
1,057,086 - Market Cap (intraday)
121.172M - Beta (5Y Monthly) 1.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1100 - Earnings Date Mar 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.78
4DMedical Limited operates as a medical technology company in the United States and Australia. It engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. The company also offers X-ray velocimetry lung ventilation analysis software (XV LVAS), a lung airflow imaging software, that provides lung health detail from X-Ray scans; computed tomography lung ventilation analysis software (CT LVAS), an image processing software which operates on CT scans to provide functional lung health detail; XV Scanner, a lung function scanner; and Permetium, a multi-function imaging system for pulmonary investigations. The company was incorporated in 2012 and is based in Carlton, Australia.
4dmedical.comRecent News: 4DX.AX
View MorePerformance Overview: 4DX.AX
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4DX.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4DX.AX
View MoreValuation Measures
Market Cap
114.86M
Enterprise Value
103.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
17.22
Price/Book (mrq)
1.92
Enterprise Value/Revenue
20.13
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.32%
Return on Equity (ttm)
-52.37%
Revenue (ttm)
5.86M
Net Income Avi to Common (ttm)
-39.54M
Diluted EPS (ttm)
-0.1100
Balance Sheet and Cash Flow
Total Cash (mrq)
15.95M
Total Debt/Equity (mrq)
8.05%
Levered Free Cash Flow (ttm)
-28.41M